AiMediq and ReOxy® at Arab Health 2025
Join us at booth H7C19
ReOxy® Featured in Newly Published Long-COVID Study
We are thrilled to announce the publication of a major clinical study conducted at MEDIAN Klinik Flechtingen, showcasing the benefits of ReOxy® for patients with long COVID.
AiMediq at MEDICA 2024
We’re Excited to Attend MEDICA 2024! Visit us in Hall 4, Booth J49
AiMediq at the ESC Preventive Cardiology 2024
This year, we are thrilled to join the ESC Preventive Cardiology 2024 in Athens — 25-27 April, booth n°B3.
Unveiling the Benefits of controlled hypoxia
In this article, we delve into the positive effects of intermittent hypoxia and explore the underlying mechanisms driving these benefits.
ESC Congress 2023, Amsterdam
This year, Ai Mediq had the privilege of participating in the European Society of Cardiology (ESC) Congress held in the city of Amsterdam. This prestigious congress brings together experts from private and public institutions worldwide to exchange knowledge and discoveries in the realm of cardiovascular medicine.
Ai Mediq at Arab Health 2023
Ai Mediq is looking forward to Arab Health 2023. Traditionally, we will be there together with delegation of Ministry of Economy at the joint booth Z1.B50.
Clinical trial outcomes for rehab after COVID
ReOxy therapy and standard rehabilitation has been shown to be as almost twice as effective compared to the standard rehabilitation (83.6 m vs 44.6 m, p<0.001).
Medica 2022
Ai Mediq is pleased to see everyone at joint booth of Ministry of Economy of Grand Duchy of Luxembourg in Dusseldorf, Germany.